A detailed history of Winslow Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Winslow Asset Management Inc holds 8,197 shares of PFE stock, worth $211,728. This represents 0.04% of its overall portfolio holdings.

Number of Shares
8,197
Previous 9,178 10.69%
Holding current value
$211,728
Previous $257,000 7.78%
% of portfolio
0.04%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$27.7 - $31.39 $27,173 - $30,793
-981 Reduced 10.69%
8,197 $237,000
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $35,540 - $41,647
-1,407 Reduced 13.29%
9,178 $257,000
Q1 2024

May 02, 2024

SELL
$25.89 - $29.73 $12,945 - $14,865
-500 Reduced 4.51%
10,585 $294,000
Q4 2023

Feb 16, 2024

SELL
$26.13 - $33.94 $47,556 - $61,770
-1,820 Reduced 14.1%
11,085 $319,000
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $962 - $1,125
-30 Reduced 0.23%
12,905 $428,000
Q1 2023

May 03, 2023

SELL
$39.39 - $51.28 $3,269 - $4,256
-83 Reduced 0.64%
12,935 $528,000
Q4 2022

Jan 23, 2023

SELL
$41.75 - $54.5 $46,050 - $60,113
-1,103 Reduced 7.81%
13,018 $667,000
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $43 - $53
-1 Reduced 0.01%
14,121 $618,000
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $11,632 - $13,792
250 Added 1.8%
14,122 $740,000
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $11,437 - $14,172
-250 Reduced 1.77%
13,872 $718,000
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $635 - $745
20 Added 0.14%
14,122 $518,000
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $86,172 - $98,246
2,240 Added 18.88%
14,102 $616,000
Q3 2018

Oct 18, 2018

SELL
$34.47 - $41.81 $249,873 - $303,080
-7,249 Reduced 37.93%
11,862 $523,000
Q3 2017

Oct 13, 2017

BUY
$31.0 - $34.15 $592,441 - $652,640
19,111
19,111 $682,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Winslow Asset Management Inc Portfolio

Follow Winslow Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Asset Management Inc with notifications on news.